HopeStage
Back to all studies
CompletedNCT01641900

Eszopiclone, Sleep and Memory in Schizophrenia and Healthy Adults

About this titleRead the official source — NCT01641900
Medication studyAges 18–45United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 45 years.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2012
Recruitment status
Completed
Enrollment listed in the registry
59
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT01641900
Official title
Show the full official title

Sleep-dependent Memory Processing in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including eszopiclone and placebo.

Who was this study for?

Listed age limits: 18 years to 45 years.

Want to explore more studies?

Explore studies